Cargando…
Role of N(6)-Methyladenosine RNA Modification in Cardiovascular Disease
Despite treatments being improved and many risk factors being identified, cardiovascular disease (CVD) is still a leading cause of mortality and disability worldwide. N(6)-methyladenosine (m(6)A) is the most common, abundant, and conserved internal modification in RNAs and plays an important role in...
Autores principales: | Song, Dandan, Hou, Jianhua, Wu, Junduo, Wang, Junnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138049/ https://www.ncbi.nlm.nih.gov/pubmed/34026872 http://dx.doi.org/10.3389/fcvm.2021.659628 |
Ejemplares similares
-
N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022) -
Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022) -
The Role of METTL3-Mediated N6-Methyladenosine (m6A) of JPH2 mRNA in Cyclophosphamide-Induced Cardiotoxicity
por: Zhu, Min, et al.
Publicado: (2021) -
Ferroptosis: a new strategy for cardiovascular disease
por: Wang, Yuyuan, et al.
Publicado: (2023) -
Transcriptome and N6-Methyladenosine RNA Methylome Analyses in Aortic Dissection and Normal Human Aorta
por: Zhou, Xianwu, et al.
Publicado: (2021)